Publication | Closed Access

Efficacy of radionuclide treatment DOTATATE Y-90 in patients with progressive metastatic gastroenteropancreatic neuroendocrine carcinomas (GEP-NETs): a phase II study

MedicineRadionuclide TherapyPhase Ii StudyRadiopharmaceutical TherapyCancer TreatmentOncologyRadiation OncologyNuclear MedicineEndocrine-related CancerRadiologyHealth Sciences